Retatrutide
Overview
Research-use triple incretin and glucagon receptor agonist supplied for studies of integrated metabolic signaling and energy-balance pathway models.
- Concentration
- 10 mg / 20 mg / 40 mg
- Stock
- In stock
Material profile
Retatrutide is a synthetic peptide designed for GLP-1, GIP, and glucagon receptor research models of integrated metabolic signaling. Pattern lists this material for controlled laboratory research.
- Research Targets
- GLP-1 receptor, GIP receptor, glucagon receptor, downstream metabolic signaling networks.
- Key Feature
- Triple receptor agonist research peptide for multi-hormone pathway studies.
- Research Focus Areas
- Incretin and glucagon signaling, glucose-regulation pathway models, energy-expenditure models, hepatic metabolic signaling.
- Common Models
- Receptor assays, rodent metabolic models, liver and adipose signaling systems.
- Mechanistic Interests
- Multi-receptor activation, insulin and glucagon signaling markers, cAMP pathway dynamics, energy-balance pathway crosstalk.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Product documentation
Certificate of Analysis
Retatrutide
Review the public certificate available for this product before creating an account or checking out.
